RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/a-2348-9264
Mortality from upper gastrointestinal tumors in colorectal cancer screening patients
Abstract
Background and study aims Currently, gastric cancer screening is only cost-effective in countries with high incidence. Integrated screening, in which gastroscopy is performed in conjunction with colonoscopy, could help reduce the gastric cancer screening procedure burden in countries with low or intermediate incidence. However, there is a lack of population-based studies to identify high-risk groups.
Methods In this retrospective analysis of a colorectal cancer (CRC) screening program database, we used Cox proportional hazards model to identify an association of high- and low-risk finding (polyps ≥ 10 mm or with high-grade dysplasia) with time to death from upper gastrointestinal cancer (esophageal and gastric). We estimated the 10-year mortality of upper gastrointestinal tumors in different 10-year age groups, stratified by sex and polyp finding at colonoscopy.
Results We included 349,856 CRC screening colonoscopies in our study. The median follow-up time was 5.22 years (95% confidence interval [CI] 5.21–5.24 years). Of the participants, 4.5% had polyps ≥ 10 mm or with high-grade dysplasia (HGD). At the end of the study period, 384 deaths from upper gastrointestinal cancer had occurred. Aside from age and sex, we found the presence of high-risk polyps to be significantly associated with upper gastrointestinal cancer death (hazard ratio 1.54, 95% CI 1.06–2.25, P = 0.025).
Conclusions CRC screening participants with polyps < 10 mm and no HGD have a lower risk for mortality from upper gastrointestinal cancers compared with participants with polyps > 10 mm and HGD. Future studies will demonstrate whether integrated screening with additional gastroscopy is effective in CRC screening participants with large or highly dysplastic polyps.
Keywords
Endoscopy Lower GI Tract - Polyps / adenomas / ... - CRC screening - Epidemiology - Endoscopic ultrasonography - Gastric cancer - Esophageal cancerPublikationsverlauf
Eingereicht: 14. Februar 2024
Angenommen nach Revision: 07. Mai 2024
Artikel online veröffentlicht:
25. Juli 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Sung H, Ferlay J, Siegel RL. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021; 71: 209-249
- 2 Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nature Rev Gastroenterol Hepatol 2021; 18: 493-502
- 3 Lauby-Secretan B, Scoccianti C, Loomis D. et al. Body fatness and cancer – Viewpoint of the IARC Working Group. N Engl J Med 2016; 375: 794-798
- 4 Poorolajal J, Moradi L, Mohammadi Y. et al. Risk factors for stomach cancer: a systematic review and meta-analysis. Epidemiol Health 2020; 42: e2020004
- 5 Tramacere I, Negri E, Pelucchi C. et al. A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol 2012; 23: 28-36
- 6 Jin G, Lv J, Yang M. et al. Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study. Lancet Oncol 2020; 21: 1378-1386
- 7 Baan R, Straif K, Grosse Y. et al. Carcinogenicity of alcoholic beverages. Lancet Oncol 2007; 8: 292-293
- 8 Kamangar F, Nasrollahzadeh D, Safiri S. et al. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2020; 5: 582-597
- 9 US Preventive Services Task Force, Davidson KW, Barry MJ. et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2021; 325: 1965-1977
- 10 Segnan N, Patnick J, von Karsa L. Screening for colorectal cancer: European guidelines. Ann Oncol 2012; 23: ix53
- 11 Weusten B, Bisschops R, Coron E. et al. Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2017; 49: 191-198
- 12 Săftoiu A, Hassan C, Areia M. et al. Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2020; 52: 293-304
- 13 Jun JK, Choi KS, Lee HY. et al. Effectiveness of the Korean National Cancer Screening Program in reducing gastric cancer mortality. Gastroenterology 2017; 152: 1319-1328.e1317
- 14 Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 321: 1273-1275
- 15 Marques-Silva L, Areia M, Elvas L. et al. Prevalence of gastric precancerous conditions: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2014; 26: 378-387
- 16 Lee Y-C, Chiang T-H, Chiu H-M. et al. Community-based gastric cancer screening coupled with a national colorectal cancer screening program: Baseline results. Gastroenterology 2021; 160: 2159-2161.e2154
- 17 Areia M, Spaander MCW, Kuipers EJ. et al. Endoscopic screening for gastric cancer: A cost-utility analysis for countries with an intermediate gastric cancer risk. United European Gastroenterol J 2018; 6: 192-202
- 18 von Karsa L, Patnick J, Segnan N. et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy 2013; 45: 51-59
- 19 Rex DK, Bond JH, Winawer S. et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2002; 97: 1296-1308
- 20 Hassan C, Antonelli G, Dumonceau JM. et al. Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020. Endoscopy 2020; 52: 687-700
- 21 Hassan C, Quintero E, Dumonceau JM. et al. Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2013; 45: 842-851
- 22 Zhang X, Li M, Chen S. et al. Endoscopic screening in Asian countries is associated with reduced gastric cancer mortality: A meta-analysis and systematic review. Gastroenterology 2018; 155: 347-354.e349
- 23 Statistik Austria: Krebserkrankungen in Österreich. 2022. Zugriff am 01. Januar 2000 unter: https://www.statistik.at/statistiken/bevoelkerung-und-soziales/gesundheit/krebserkrankungen
- 24 Steevens J, Schouten LJ, Goldbohm RA. et al. Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut 2010; 59: 39
- 25 Smyth EC, Nilsson M, Grabsch HI. et al. Gastric cancer. Lancet 2020; 396: 635-648
- 26 Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 2007; 10: 75-83
- 27 Siegel RL, Miller KD, Wagle NS. et al. Cancer statistics, 2023. CA Cancer J Clin 2023; 73: 17-48
- 28 Sena VD, Opanasets L, Ookubo R. et al. Gender differences in gastroesophageal reflux disease: Myth or reality?. Gastrointest Endosc 2004; 59: P112
- 29 Waldmann E, Heinze G, Ferlitsch A. et al. Risk factors cannot explain the higher prevalence rates of precancerous colorectal lesions in men. Br J Cancer 2016; 115: 1421-1429
- 30 Yang YJ, Bang CS, Choi JH. et al. Alcohol consumption is associated with the risk of developing colorectal neoplasia: Propensity score matching analysis. Sci Rep 2019; 9: 8253
- 31 Okabayashi K, Ashrafian H, Hasegawa H. et al. Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol 2012; 107: 1175-1185
- 32 Pimentel-Nunes P, Libânio D, Marcos-Pinto R. et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy 2019; 51: 365-388
- 33 Evans JA, Chandrasekhara V, Chathadi KV. et al. The role of endoscopy in the management of premalignant and malignant conditions of the stomach. Gastrointest Endosc 2015; 82: 1-8
- 34 Hvid-Jensen F, Pedersen L, Drewes AM. et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011; 365: 1375-1383
- 35 Yan L, Chen Y, Chen F. et al. Effect of Helicobacter pylori eradication on gastric cancer prevention: Updated report from a randomized controlled trial with 26. 5 years of follow-up. Gastroenterology 2022; 163: 154-162.e153
- 36 Leung WK, Ho HJ, Lin J-T. et al. Prior gastroscopy and mortality in patients with gastric cancer: a matched retrospective cohort study. Gastrointest Endosc 2018; 87: 119-127.e113
- 37 Hippisley-Cox J, Coupland C. Identifying patients with suspected gastro-oesophageal cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract 2011; 61: e707-714